Edgestream Partners L.P. Sells 44,509 Shares of Zoetis Inc. $ZTS

Edgestream Partners L.P. lessened its stake in Zoetis Inc. (NYSE:ZTS) by 80.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,110 shares of the company’s stock after selling 44,509 shares during the quarter. Edgestream Partners L.P.’s holdings in Zoetis were worth $1,733,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Zoetis in the 2nd quarter valued at about $809,491,000. Nuveen LLC acquired a new stake in Zoetis in the 1st quarter valued at about $616,375,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Zoetis by 113.0% during the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,761,920 shares of the company’s stock worth $586,671,000 after purchasing an additional 1,995,491 shares during the period. Polen Capital Management LLC increased its position in Zoetis by 17.6% during the first quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock worth $1,448,401,000 after buying an additional 1,313,653 shares during the last quarter. Finally, Impax Asset Management Group plc raised its stake in Zoetis by 362.6% in the second quarter. Impax Asset Management Group plc now owns 1,176,996 shares of the company’s stock valued at $182,705,000 after buying an additional 922,589 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have recently commented on ZTS. BTIG Research reissued a “buy” rating and set a $160.00 target price on shares of Zoetis in a report on Wednesday. Morgan Stanley reduced their price objective on shares of Zoetis from $211.00 to $175.00 and set an “overweight” rating for the company in a research report on Monday, November 10th. KeyCorp initiated coverage on shares of Zoetis in a report on Thursday, November 20th. They issued a “sector weight” rating on the stock. Stifel Nicolaus cut their target price on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a research note on Tuesday, November 18th. Finally, Argus reiterated a “buy” rating and issued a $190.00 price target on shares of Zoetis in a research note on Tuesday, September 9th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Zoetis currently has a consensus rating of “Moderate Buy” and a consensus price target of $178.89.

Zoetis Stock Down 1.4%

ZTS opened at $118.69 on Friday. The stock has a fifty day moving average of $133.77 and a 200-day moving average of $147.78. The company has a market capitalization of $52.31 billion, a P/E ratio of 19.98, a P/E/G ratio of 2.50 and a beta of 0.97. Zoetis Inc. has a fifty-two week low of $115.25 and a fifty-two week high of $181.85. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.28 and a current ratio of 3.64.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The business had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. During the same period last year, the firm earned $1.58 earnings per share. Zoetis’s revenue for the quarter was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date was Friday, October 31st. Zoetis’s payout ratio is presently 33.67%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.